Skip to content
Screener

ImmunityBio, Inc. IBRX Gain (loss) on disposal of assets

Gain (loss) on disposal of assets at other companies

Adobe logo
AdobeADBE
$18M+800%
Iris Energy logo
Iris EnergyIREN
$234K-84.7%
Hewlett Packard Enterprise logo
Hewlett Packard EnterpriseHPE
$0
Zoom Video Communications, Inc. logo
Zoom Video Communications, Inc.ZM
$152.3M+1,218%
KEE
Keel InfrastructureKEEL
-$1K-100%
Brookdale Senior Living logo
Brookdale Senior LivingBKD
$4.03M

Segments

By segment

See full
Reportable Segment$2.31M+161%

Other financials

Income statement

See full
Revenue$44.2M+168%
Gross profit$44.0M+167%
Operating income-$69.8M-8.3%
Net income-$632.8M-388%
EPS (diluted)-$0.62-313%

Balance sheet

See full
Cash & equivalents$205.2M+238%
Total debt$445.4M+32.2%
Total equity-$870.0M-47.1%
Total assets$646.6M+113%

Cash flow

See full
Operating cash flow-$75.4M+12.3%
CapEx$1.8M+58.4%
Free cash flow-$77.1M+11.4%

Valuation

See full
Market cap$7.68B+242%
Enterprise value$7.92B+227%
P/S54.5×+14.8×

Profitability

See full
Gross margin99.3%-0.5pp
Operating margin-185.4%-83.3pp
Net margin-606.2%-212pp
FCF margin-212%-95.8pp

Returns & leverage

See full
Return on equity-119.3%
Debt / equity0.1×
Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnInvestments.

The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 7:37 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001326110-26-000059
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Total operating costs and expenses113,99780,946
Loss from operations(69,791)(64,429)
Other income (expense), net
Interest and investment income, net2,314887
Change in fair value of warrant liabilities(295,413)(448)
Change in fair value of related-party convertible note(236,625)(42,582)
Interest expense – related party(14,559)(15,313)
Interest expense related to revenue interest liability(13,871)(13,534)

ITEM 1. FINANCIAL STATEMENTS.

FAQ

What is ImmunityBio, Inc.'s gain (loss) on disposal of assets?
ImmunityBio, Inc. (IBRX) reported gain (loss) on disposal of assets of $2.31M in Q1 2026.
How has ImmunityBio, Inc.'s gain (loss) on disposal of assets changed year-over-year?
ImmunityBio, Inc.'s gain (loss) on disposal of assets increased by 160.9% year-over-year, from $887K to $2.31M.
What is the long-term trend for ImmunityBio, Inc.'s gain (loss) on disposal of assets?
Over 4 years (2021 to 2025), ImmunityBio, Inc.'s gain (loss) on disposal of assets has grown at a 11.8% compound annual growth rate (CAGR), from -$4.1M to $6.41M.
What does gain (loss) on disposal of assets mean?
Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.

Ask your AI about ImmunityBio, Inc.'s gain (loss) on disposal of assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude